Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesMRI‘Dark-light-dark sign’ on MRI predicts rectal cancer metastasisAbsence of the novel tumor feature on contrast-enhanced T1-weighted imaging was associated with a higher risk of lymph node metastasis.CTCT-based model assesses lung lesions from nonsolid nodulesMRIMRI reveals how statins reduce vessel wall inflammationMolecular ImagingNew PET tracer helps detect pulmonary sarcoidosisInterventionalTransarterial embolization, cryoablation treat larger renal masses